Abstract
Human mesenchymal stem cells (hMSCs) are multipotent cells that can differentiate into various tissue types, including bone, cartilage, tendon, adipocytes, and marrow stroma, making them potentially useful for human cell and gene therapies. Our objective was to demonstrate the utility of glass needle-mediated microinjection as a method to deliver macromolecules (e.g. dextrans, DNA) to hMSCs for cell and molecular biological studies. hMSCs were isolated and cultured using a specific fetal bovine serum, prescreened for its ability to promote cell adherence, proliferation, and osteogenic differentiation. Successful delivery of Oregon Green-dextran via intranuclear microinjection was achieved, yielding a postinjection viability of 76 ± 13%. Excellent short-term gene expression (63 ± 11%) was achieved following microinjection of GFP-containing vectors into hMSCs. Higher efficiencies of short-term gene expression (∼5-fold) were observed when injecting supercoiled DNA, pYA721, as compared with the same DNA construct in a linearized form, YA721. Approximately 0.05% of hMSCs injected with pYA721 containing both the GFP and neomycin resistance genes formed GFP-positive, drug-resistant colonies that survived >120 days. Injection of linearized YA721 resulted in 3.6% of injected hMSC forming drug-resistant colonies, none of which expressed GFP that survived 60–120 days. These studies demonstrate that glass needle-mediated microinjection can be used as a method of delivering macromolecules to hMSCs and may prove to be a useful technique for molecular and cell biological mechanistic studies and future genetic modification of hMSCs.
Similar content being viewed by others
References
Alberts A, Montminy M, Shenolikar S, Feramisco J. Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 14:4398–4407;1994.
Ansorge W. Improved system for capillary microinjection into living cells. Exp Cell Res 140:31–37;1982.
Ansorge W, Pepperkok R. Performance of an automated system for capillary microinjection into living cells. J Biochem Biophys Methods 16:283–292;1988.
Ashton BA, Abdullah F, Cave J, Williamson M, Sykes BC, Couch M, Poser JW. Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow: Preliminary assessment of their osteogenicity. Bone 6:313–319;1985.
Bruder SP, Horowitz MC, Haynesworth SE. Monoclonal antibodies selective for human osteogenic cell surface antigens. Bone 21:225–235;1997.
Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following criopreservation. J Cell Biochem 64:278–294;1997.
Caplan AI. Mesenchymal stem cells. J Orthop Res 9:641–650;1991.
Caplan AI. Mesenchymal stem cells and gene therapy. Clin Orthop Res (379 suppl):S67–S70;2000.
Capecchi M. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22:479–488;1980.
Chung JH, Bell AC, Felsenfeld G. Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci USA 94:575–580;1997.
Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 6:1574–1583;1999.
Colosimo A, Gonecz KK, Novelli G, Dallapiccola B, Gruenert DC. Targeted correction of defective selectable marker gene in human epithelial cells by small DNA fragments. Mol Ther 3:178–185;2001.
Davis BR, Brown DB, Prokopishyn NL, Yannariello-Brown J. Micro-injection-mediated hematopoietic stem cell gene therapy. Curr Opin Mol Ther 2:412–419;2000.
Davis BR, Yannariello-Brown J, Prokopishyn NL, Wang J, Smith M, Lou ZJ, Brown DB. Microinjection-mediated delivery of macromolecules and transgenes to primary human blood stem/progenitor cells. Blood 95:437–444;2000.
Ferrari G, Angelis GC, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528–1530;1998.
Flanagan WM, Wagner RW. Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem 172:213–225;1997.
Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson F, Hall FL. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-β1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 8:1385–1394;1997.
Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263–272;1987.
Golde D, Hocking W, Quan S, Sparkes R, Gale R. Origin of the human bone marrow fibroblasts. Br J Hematol 44:183–187;1980.
Goncz KK, Gruenert DC. Site-directed alteration of genomic DNA by small-fragment homologous replacement. Methods Mol Biol 133:85–99;2000.
Gruenert DC. Opportunities and challenges in targeting genes for therapy. Gene Ther 6:1347–1348;1999.
Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 13:81–88;1992.
Haynesworth SE, Baber MA, Caplan AI. Characterization of the unique mesenchymal stem cell phenotype in vitro. Trans Orthop Res Soc 29:641–649;1995.
Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Kneel M, Busman M, Orchard P, Marx JC, Pyeritz RE, Brener KM. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313;1999.
Hyland JK, Rogers CM, Scolnick EM, Stein RB, Ellis R, Baserga R. Microinjectedras family oncogenes stimulate DNA synthesis in quiescent mammalian cells. Virology 141:333–336;1985.
Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295–312;1997.
Johnstone B, Yoo JU, Barry F. In vitro chondrogenesis of bone marrow-derived mesenchymal cells. Exp Cell Res 238:265–272;1998.
Kmiec EB, Ye S, Peng L. Targeted gene repair in mammalian cells using chimeric oligonucleotides. Genet Eng 22:23–31;2000.
Lajtha LG. Tissues and stem cells. Biomed Pharmacother 36:231–233;1982.
Lamb NJC, Fernandez A. Microinjection of antibodies into mammalian cells. Methods Enzymol 283:72–83;1997.
Lazarus H, Haynesworth SE, Gerson S, Rosenthal N, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implication for therapeutic use. Bone Marrow Transplant 16:557–564;1995.
Legerski RJ, Brown DB, Peterson CA, Robberson DL. Transient complementation ofXeroderma pigmentosum cells by microinjection of poly (A)+RNA. Proc Natl Acad Sci USA 81:5676–5679;1984.
Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32:602–611;1996.
Liu L, Rice MC, Kmiec EB. In vivo gene repair of point and frame shift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 29:4238–4250;2001.
Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415–428;1998.
Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57–66;1998.
Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hematopoietic microenvironment. Eur J Hematol 49:225–233;1992.
Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239–4242;1990.
Miskimins WK, Brown DB. Analysis of cis-acting promoter elements using microinjected synthetic oligonucleotides. Exp Cell Res 191:328–331;1990.
Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang CL, Majumdar M, Chopra R, Barry F, Murphy M, Thiede M, Junker U, Rigg R, Forestell S, Bohnlein E, Storb R, Sanmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop Relat Res (379 suppl):S71–S90;2000.
Nakahara H, Goldberg V, Caplan AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9:465–478;1991.
Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844–2853;1993.
Pepperkok R, Schneider C, Philipson L, Ansorge W. Single cell assay with an automated capillary microinjection system. Exp Cell Res 178:369–376;1988.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147;1999.
Pittenger MF, Mosca JD, Mcintosh KR. Human mesenchymal stem cells: Progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 251:3–11;2000.
Pittenger MF, Mackay AM, Beck SC. Human mesenchymal stem cells can be directed into chondrocytes, adipocytes and osteocytes (abstract 1772). Mol Biol Cell 7:305;1996.
Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276:71–75;1997.
Recillas-Targa F, Bell AC, Felsenfeld G. Positional enhancer-blocking activity of the chicken beta-globin insulator in transiently transfected cells. Proc Natl Acad Sci USA 96:14354–14357;1999.
Rice MC, Czymmek K, Kmiec EB. The potential of nucleic acid repair in functional genomics. Nat Biotechnol 19:321–326;2001.
Rodan G, Martin TJ. Therapeutic approaches to bone diseases. Tissue engineers build new bone. Science 289:1498–1500, 1508–1514;2000.
Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 1:91–99;2001.
Stacey D. Microinjection of mRNA and other macromolecules into living cells. Methods Enzymol 79:76–88;1981.
Stacey DW, Hsiang-Fu K. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 310:508–511;1984.
Tezuka K, Yasuda M, Watanabe N, Morimura N, Kuroda K, Miyatani S, Hozumi N. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 17:231–239;2002.
Verma IM, Somia N. Gene therapy — Promises, problems and prospects. Nature 389:239–242;1997.
Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. Regulatory systems for use in gene transfer. Proc Natl Acad Sci USA 91:8180–8184;1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsulaia, T.V., Prokopishyn, N.L., Yao, A. et al. Glass needle-mediated microinjection of macromolecules and transgenes into primary human mesenchymal stem cells. J Biomed Sci 10, 328–336 (2003). https://doi.org/10.1007/BF02256452
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02256452